| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Walsh Angela | Chief Financial Officer | C/O DOGWOOD THERAPEUTICS, INC., 44 MILTON AVENUE, ALPHARETTA | /s/ Greg Duncan, Attorney-in-Fact | 01 Jul 2025 | 0001825987 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DWTX | Stock Option (right to buy) | Award | $0 | +12,075 | $0.000000 | 12,075 | 27 Jun 2025 | Common Stock | 12,075 | $4.71 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | The stock option vests one-third on June 27, 2026 and 1/24th monthly thereafter. |